Role of socio-economic factors in visual impairment and progression of diabetic retinopathy.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
03 2021
Historique:
received: 30 03 2020
revised: 21 04 2020
accepted: 29 04 2020
pubmed: 21 5 2020
medline: 16 6 2021
entrez: 21 5 2020
Statut: ppublish

Résumé

To investigate the longitudinal associations between person-level and area-level socioeconomic status (PLSES and ALSES, respectively) with diabetic retinopathy (DR) and visual impairment (VI) in Asians with diabetes mellitus (DM). In this population-based cohort study, we included 468 (39.4%) Malays and 721 (60.6%) Indians with DM, with a mean age (SD) of 58.9 (9.1) years; 50.6% were female and the mean follow-up duration was 6.2 (0.9) years. Individual PLSES parameters (education, monthly income and housing type) were quantified using questionnaires. ALSES was assessed using the Socioeconomic Disadvantage Index derived from Singapore's 2010 areal census (higher scores indicate greater disadvantage). Incident DR and VI were defined as absent at baseline but present at follow-up, while DR and VI progression were defined as a ≥1 step increase in severity category at follow-up. Modified Poisson regression analysis was used to determine the associations of PLSES and ALSES with incidence and progression of DR and VI, adjusting for relevant confounders. In multivariable models, per SD increase in ALSES score was associated with greater DR incidence (risk ratio (95% CI) 1.27 (1.13 to 1.44)), DR progression (1.10 (1.00 to 1.20)) and VI incidence (1.10 (1.04 to 1.16)), while lower PLSES variables were associated with increased DR (low income: 1.68 (1.21 to 2.34)) and VI (low income: 1.44 (1.13 to 1.83); ≤4 room housing: 2.00 (1.57 to 2.54)) incidence. We found that both PLSES and ALSES variables were independently associated with DR incidence, progression and associated vision loss in Asians. Novel intervention strategies targeted at low socioeconomic status communities to decrease rates of DR and VI are warranted.

Sections du résumé

BACKGROUND
To investigate the longitudinal associations between person-level and area-level socioeconomic status (PLSES and ALSES, respectively) with diabetic retinopathy (DR) and visual impairment (VI) in Asians with diabetes mellitus (DM).
METHODS
In this population-based cohort study, we included 468 (39.4%) Malays and 721 (60.6%) Indians with DM, with a mean age (SD) of 58.9 (9.1) years; 50.6% were female and the mean follow-up duration was 6.2 (0.9) years. Individual PLSES parameters (education, monthly income and housing type) were quantified using questionnaires. ALSES was assessed using the Socioeconomic Disadvantage Index derived from Singapore's 2010 areal census (higher scores indicate greater disadvantage). Incident DR and VI were defined as absent at baseline but present at follow-up, while DR and VI progression were defined as a ≥1 step increase in severity category at follow-up. Modified Poisson regression analysis was used to determine the associations of PLSES and ALSES with incidence and progression of DR and VI, adjusting for relevant confounders.
RESULTS
In multivariable models, per SD increase in ALSES score was associated with greater DR incidence (risk ratio (95% CI) 1.27 (1.13 to 1.44)), DR progression (1.10 (1.00 to 1.20)) and VI incidence (1.10 (1.04 to 1.16)), while lower PLSES variables were associated with increased DR (low income: 1.68 (1.21 to 2.34)) and VI (low income: 1.44 (1.13 to 1.83); ≤4 room housing: 2.00 (1.57 to 2.54)) incidence.
CONCLUSIONS
We found that both PLSES and ALSES variables were independently associated with DR incidence, progression and associated vision loss in Asians. Novel intervention strategies targeted at low socioeconomic status communities to decrease rates of DR and VI are warranted.

Identifiants

pubmed: 32430341
pii: bjophthalmol-2020-316430
doi: 10.1136/bjophthalmol-2020-316430
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

420-425

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Jin Rong Low (JR)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.

Alfred Tau Liang Gan (ATL)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.

Eva K Fenwick (EK)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.
Duke-NUS Medical School, Singapore.

Preeti Gupta (P)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.

Tien Y Wong (TY)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.
Duke-NUS Medical School, Singapore.
National University of Singapore, Singapore.

Zhen Ling Teo (ZL)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.

Sahil Thakur (S)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.

Yih Chung Tham (YC)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.
Duke-NUS Medical School, Singapore.

Charumathi Sabanayagam (C)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.
Duke-NUS Medical School, Singapore.
National University of Singapore, Singapore.

Ching-Yu Cheng (CY)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.
Duke-NUS Medical School, Singapore.
National University of Singapore, Singapore.

Ecosse Luc Lamoureux (EL)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore ecosse.lamoureux@seri.com.sg.
Duke-NUS Medical School, Singapore.
National University of Singapore, Singapore.

Ryan Eyn Kidd Man (REK)

Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore.
Duke-NUS Medical School, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH